Metagenomi, Inc., was incorporated in Delaware in September 2016. The company is a precision genetic medicine company dedicated to the development of therapeutic drugs for patients using a proprietary, comprehensive metagenomics-derived genome editing toolkit. Inherited diseases are caused by a series of different mutations that have so far been largely unavailable with genomic engineering methods. Gene mutations occur in many forms, including deletions, insertions, single-base pair changes, and sequence repeats, and are found throughout the genome and in a variety of different cell types, tissues, and organ systems. 

MGX

MGX Profile